Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-06
DOI
10.1007/s40261-018-0693-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease
- (2016) Arman Qamar et al. CIRCULATION
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography
- (2016) Ilaria Dentamaro et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study
- (2016) Richard L. Amdur et al. PLoS One
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
- (2015) Yukihiro Koretsune et al. CIRCULATION JOURNAL
- Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa
- (2015) Dolly A. Parasrampuria et al. CLINICAL PHARMACOKINETICS
- Changes in Renal Function in Patients With Atrial Fibrillation
- (2015) Michael Böhm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
- (2014) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
- (2014) Anders Nissen Bonde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)
- (2013) Vanessa Roldán et al. AMERICAN JOURNAL OF CARDIOLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype
- (2012) Leon J. Schurgers et al. PLoS One
- Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation
- (2011) Alvaro Alonso et al. CIRCULATION
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation
- (2011) K. Ware et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
- (2011) Sergey V. Brodsky et al. KIDNEY INTERNATIONAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
- (2010) AMERICAN HEART JOURNAL
- Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States
- (2010) Usman Baber et al. Circulation-Arrhythmia and Electrophysiology
- Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
- (2010) F. Yang et al. EUROPACE
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of CKD in the United States: A Sensitivity Analysis Using the National Health and Nutrition Examination Survey (NHANES) 1999-2004
- (2008) Jon J. Snyder et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sympathetic Activation in Chronic Renal Failure
- (2008) M. P. Schlaich et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation